Evidence map›Paper›PMID 39012101›Full record

ArticleApplied and environmental microbiology2024

Josefina Duran-Bedolla, Juan Téllez-Sosa, Paola Bocanegra-Ibarias, Astrid Schilmann, Sugey Bravo-Romero, Fernando Reyna-Flores, Tania Villa-Reyes, Humberto Barrios-Camacho

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Josefina Duran-Bedolla *Instituto Nacional de Salud Pública (INSP), Centro de Investigación Sobre Enfermedades Infecciosas (CISEI), Cuernavaca, Morelos, Mexico.
Juan Téllez-Sosa *Instituto Nacional de Salud Pública (INSP), Centro de Investigación Sobre Enfermedades Infecciosas (CISEI), Cuernavaca, Morelos, Mexico.
Paola Bocanegra-IbariasFacultad de Medicina, Hospital Universitario "Dr. José Eleuterio González", Departamento de Enfermedades Infecciosas, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Astrid SchilmannInstituto Nacional de Salud Pública (INSP), Centro de Investigación en Salud Poblacional, Cuernavaca, Morelos, Mexico.
Sugey Bravo-RomeroInstituto Nacional de Salud Pública (INSP), Centro de Investigación Sobre Enfermedades Infecciosas (CISEI), Cuernavaca, Morelos, Mexico.
Fernando Reyna-FloresInstituto Nacional de Salud Pública (INSP), Centro de Investigación Sobre Enfermedades Infecciosas (CISEI), Cuernavaca, Morelos, Mexico.
Tania Villa-ReyesCoordinación Nacional de la Red Hospitalaria de Vigilancia Epidemiológica, Dirección General de Epidemiología, Ciudad de México, Mexico.
Humberto Barrios-CamachoInstituto Nacional de Salud Pública (INSP), Centro de Investigación Sobre Enfermedades Infecciosas (CISEI), Cuernavaca, Morelos, Mexico.ORCID 0000-0001-7563-9392

Funding

CONAGUA 001
6 · The paper itself

Abstract

Antibiotic resistance has emerged as a global threat to public health, generating a growing interest in investigating the presence of antibiotic-resistant bacteria in environments influenced by anthropogenic activities. Wastewater treatment plants in hospital serve as significant reservoirs of antimicrobial-resistant bacteria, where a favorable environment is established, promoting the proliferation and transfer of resistance genes among different bacterial species. In our study, we isolated a total of 243 strains from 5 hospital wastewater sites in Mexico, belonging to 21 distinct Gram-negative bacterial species. The presence of β-lactamase was detected in 46.9% (114/243) of the isolates, which belonging to the IMPORTANCE: The significance of this study lies in its findings regarding the prevalence and diversity of antibiotic-resistant bacteria and genes identified in hospital wastewater in Mexico. The research underscores the urgent need for enhanced surveillance and prevention strategies to tackle the escalating challenge of antibiotic resistance, particularly evident through the elevated frequencies of carbapenemase genes such as

Indexed as

Bacterial Proteinsbeta-LactamasesCitrobacterEnterobacterHospitalsWastewaterAnti-Bacterial AgentsMexicoAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseWastewatercarbapenemaseCitrobacterEnterobacterNDM-1wastewater

Identifiers

PMID39012101
PMCPMC11337798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.